Analysis of the composition of plasma lipoproteins in patients with extensive coronary heart disease using 1H NMR spectroscopy

Hellenic Journal of Cardiology

Volumn 49, Issue 2, 2008, Pages 72-78

  Papathanasiou, Athanasios ^a,c   Kostara, Christina ^a   Cung, Manh Thong ^b   Seferiadis, Konstantin ^a   Elisaf, Moses ^a   Bairaktari, Eleni ^a   Goudevenos, Ioannis A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b LAB DE CHIM PHYS MACROMOLECULAIRE   (France)

^c NONE   (Greece)

Author keywords

1H NMR; Composition; Coronary heart disease; Lipoproteins

Indexed keywords

DEXTRAN SULFATE; HIGH DENSITY LIPOPROTEIN; MAGNESIUM CHLORIDE; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY RISK; DISEASE SEVERITY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

AGED; CASE-CONTROL STUDIES; CHOLESTEROL; CORONARY DISEASE; FATTY ACIDS; FEMALE; HUMANS; LIPOPROTEINS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 43049122130     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Sparks DL, Davidson WS, Lund-Katz S, Phillips MC: Effects of the neutral lipid content of high density lipoprotein on apolipoprotein A-I structure and particle stability. J Biol Chem 1995; 270: 26910-26917.
2. Bagdade JD, Buchanan WF, Pollare T, Lithell H: Abnormal lipoprotein phospholipid composition in patients with essential hypertension. Atherosclerosis 1995; 117: 209-215.
3. Hasselwander O, McEneny J, McMaster D, et al: HDL composition and HDL antioxidant capacity in patients on regular haemodialysis. Atherosclerosis 1999; 143: 125-133.
4. Naito HK, Greenstreet RL, David JA, et al: HDL-cholesterol concentration and severity of coronary atherosclerosis determined by cine-angiography. Artery 1980; 8: 101-112.
5. Kunz F, Pechlaner C, Erhart R, Fend F, Muhlberger V: HDL and plasma phospholipids in coronary artery disease. Arterioscler Thromb 1994; 14: 1146-1150.
6. Piperi C, Kalofoutis C, Papaevaggeliou D, Papapanagiotou A, Lekakis J, Kalofoutis A: The significance of serum HDL phospholipid levels in angiographically defined coronary artery disease. Clin Biochem 2004; 37: 377-381.
7. Horter MJ, Sondermann S, Reinecke H, et al: Associations of HDL phospholipids and paraoxonase activity with coronary heart disease in postmenopausal women. Acta Physiol Scand 2002; 176: 123-130.
8. Cushley RJ, Okon M, ark: NMR studies of lipoprotein structure. Annu Rev Biophys Biomol Struct 2002; 31: 177-206.
9. Otvos JD: Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy, in Rifai N, Warnick GR, Dominiczak MH (eds.): Handbook of lipoprotein testing. AACC Press, Washington, 1997; pp 497-508.
10. Brindle JT, Antti H, Holmes E, et al: Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 2002; 8: 1439-1444.
11. Warnick GR, Benderson J, Albers JJ: Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982; 28: 1379-1388.
12. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917.
13. Sparling ML, Zidovetzki R, Muller L, Chan SI: Analysis of membrane lipids by 500MHz 1H NMR. Anal Biochem 1989; 178: 67-76.
14. Kriat M, Vion-Dury J, Confort-Gouny S, et al: Analysis of plasma lipids by NMR spectroscopy: application to modifications induced by malignant tumors. J Lipid Res 1993; 34: 1009-1019.
15. Noula C, Bonzom P, Brown A, Gibbons WA, Martin J, Nicolaou A: 1H-NMR lipid profiles of human blood platelets; links with coronary artery disease. Biochim Biophys Acta 2000; 1487: 15-23.
16. Tsironis LD, Katsouras CS, Goudevenos JA, et al: Lipoprotein(a)- associated PAF-acetylhydrolase activity in patients with coronary artery disease. Hellenic J Cardiol 2003; 44: 32-37.
17. Lee J, Leeson PC: Lipoproteins and the endothelium: past, present and future. Hellenic J Cardiol 2006; 47: 158-159.
18. Antoniades C, Tousoulis D, Marinou K, et al: Effects of lipid profile on forearm hyperemic response in young subjects. Hellenic J Cardiol 2006; 47: 152-157.
19. Kolovou GD, Anagnostopoulou KK, Salpea KD, et al: Influence of triglycerides on other plasma lipids in middle-aged men intended for hypolipidaemic treatment. Hellenic J Cardiol 2006; 47: 78-83.
20. Curtiss LK, Bonnet DJ, Rye KA: The conformation of apolipoprotein A-I in high density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study. Biochemistry 2000; 39: 5712-5721.
21. Rye KA, Hime NJ, Barter PJ: The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins. J Biol Chem 1996; 271: 4243-4250.
22. Fournier N, Paul JL, Atger V, et al: HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler Thromb Vasc Biol 1997; 17: 2685-2691.
23. Yancey PG, de la Llera-Moya M, Swarnakar S, et al: High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J Biol Chem 2000; 275: 36596-36604.
24. Nofer JR, Walter M, Assmann G: Current understanding of the role of high-density lipoproteins in atherosclerosis and senescence. Expert Rev Cardiovasc Ther 2005; 3: 1063-1078.
25. Koulouris SN: HDL-cholesterol: pro-inflammatory and anti-inflammatory effects. Hellenic J Cardiol 2004; 45: 324-330.
26. Ascherio A: Epidemiological studies on dietary fats and coronary heart disease. Am J Med 2002; 113: 9S-12S.
27. Von S, Chacky C: Omega-3 fatty acids and cardiovascular disease. Curr Opin Clin Nutr Metab Care 2004; 7: 131-136.
28. Lopez-Garcia E, Schulze MB, Manson JE, et al: Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004; 134: 1806-1811.